Type 1 diabetes – Page 3

Preclinical and clinical testing of a stem cell-based combination product for insulin-dependent diabetes

Post author:
Post published:September 12, 2024
Post category:

ViaCyte is developing cell therapies to replace lost pancreatic beta cells for people with type 1 diabetes (T1D). The therapies are derived from human embryonic stem cells, which are partially…

Immune cloaking of human stem cell-derived insulin-producing cells for curative cell therapy without immunosuppression

Post author:
Post published:September 12, 2024
Post category:

Research Objective The goal of our project is to generate cells for replacement therapy in patients that have reduced ability to trigger the immune response in the recipient and therefore…

Go to the previous page
1
2
3

Subscribe to Receive CIRM News